Sutro Biopharma Inc
NASDAQ:STRO
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.28
5.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Sutro Biopharma Inc
Wall Street
Price Targets
STRO Price Targets Summary
Sutro Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
STRO
is 12.24 USD
with a low forecast of 5.05 USD and a high forecast of 21 USD.
STRO Last Price Targets
Sutro Biopharma Inc
The latest public price target was made on Oct 11, 2024 by
Tazeen Ahmad
from
Bank of America Securities
,
who expects
STRO
stock to
rise by 367%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Tazeen Ahmad
Bank of America Securities
|
12
USD
Upside 367% |
1 month ago
Oct 11, 2024
|
BofA Securities Reiterates Buy Rating on Sutro Biopharma (STRO)
StreetInsider
|
|
Andrew Fein
H.C. Wainwright
|
12
USD
Upside 367% |
1 month ago
Oct 11, 2024
|
H.C. Wainwright Reiterates Buy Rating on Sutro Biopharma (STRO)
StreetInsider
|
Asthika Goonewardene
Truist Financial
|
15
USD
Upside 484% |
3 months ago
Aug 16, 2024
|
Sutro Biopharma (STRO) PT Lowered to $15 at Truist Securities
StreetInsider
|
David Nierengarten
Wedbush
|
8
USD
Upside 211% |
6 months ago
May 14, 2024
|
Wedbush Reiterates Outperform Rating on Sutro Biopharma (STRO)
StreetInsider
|
James Shin
Deutsche Bank
|
10
USD
Upside 289% |
6 months ago
May 14, 2024
|
Sutro Biopharma (STRO) PT Lowered to $10 at Deutsche Bank
StreetInsider
|
Edward Tenthoff
Piper Sandler
|
11
USD
Upside 328% |
7 months ago
Apr 3, 2024
|
Sutro Biopharma (STRO) PT Lowered to $11 at Piper Sandler
StreetInsider
|
Jay Olson
Oppenheimer
|
10
USD
Upside 289% |
7 months ago
Apr 3, 2024
|
Oppenheimer Reiterates Outperform Rating on Sutro Biopharma (STRO)
StreetInsider
|
|
Asthika Goonewardene
Truist Financial
|
18
USD
Upside 600% |
7 months ago
Apr 2, 2024
|
Sutro Biopharma (STRO) PT Lowered to $18 at Truist Securities
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is STRO's stock price target?
Price Target
12.24
USD
According to Wall Street analysts, the average 1-year price target for
STRO
is 12.24 USD
with a low forecast of 5.05 USD and a high forecast of 21 USD.
What is Sutro Biopharma Inc's Revenue forecast?
Projected CAGR
-21%
For the last 6 years the
compound annual growth rate for
Sutro Biopharma Inc's revenue is
20%.
The projected
CAGR
for the next 3 years is
-21%.
You don't have any saved screeners yet
